European evidence-based consensus on the management of ulcerative colitis: current management

SPL Travis, EF Stange, M Lémann… - Journal of Crohn's …, 2008 - academic.oup.com
The general principles for treating active ulcerative colitis are to consider the activity,
distribution (proctitis, left-sided, extensive, 1 and pattern of disease (relapse frequency …

The role of stress in the mosaic of autoimmunity: an overlooked association

K Sharif, A Watad, L Coplan, B Lichtbroun… - Autoimmunity …, 2018 - Elsevier
Stress is defined as the pscyophysiological reaction in which the steady state is disturbed or
threatened. Stress is not always perceived as a negative response. Stress results when …

Third European evidence-based consensus on diagnosis and management of ulcerative colitis. Part 2: current management

M Harbord, R Eliakim, D Bettenworth… - Journal of Crohn's …, 2017 - academic.oup.com
11.1. General The treatment strategy for ulcerative colitis [UC] is mainly based on the
severity, distribution [proctitis, left-sided, extensive] 1 and pattern of disease. The latter …

Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 2: current management

A Dignass, JO Lindsay, A Sturm… - Journal of Crohn's …, 2012 - academic.oup.com
When deciding the appropriate treatment strategy for active ulcerative colitis one should
consider the activity, distribution (proctitis, left-sided, extensive 1), and pattern of disease …

Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 3: special situations

G Van Assche, A Dignass, B Bokemeyer… - Journal of Crohn's …, 2013 - academic.oup.com
Second European evidence-based consensus on the diagnosis and management of ulcerative
colitis Part 3: Special situations | Journal of Crohn's and Colitis | Oxford Academic Skip to …

Predicting relapse in Crohn's disease: a biopsychosocial model

A Bitton, PL Dobkin, MD Edwardes, MJ Sewitch… - Gut, 2008 - gut.bmj.com
Background: Crohn's disease (CD) is a chronic relapsing inflammatory bowel disorder. Both
biological and psychosocial factors may modulate the illness experience. Aim: The aim of …

Inflammatory bowel diseases: review of known environmental protective and risk factors involved

KWJ van der Sloot, M Amini, V Peters… - Inflammatory bowel …, 2017 - academic.oup.com
Inflammatory bowel diseases consisting of Crohn's disease and ulcerative colitis are chronic
inflammatory diseases of the gastrointestinal tract. In addition to genetic susceptibility and …

Health-related quality of life in inflammatory bowel disease: psychosocial, clinical, socioeconomic, and demographic predictors

A Moradkhani, LJ Beckman… - Journal of Crohn's and …, 2013 - academic.oup.com
Background and aims: Individuals with inflammatory bowel disease (IBD) have impaired
health-related quality of life (HRQOL). Managing HRQOL is increasingly becoming an …

The role of stress in the development and clinical course of inflammatory bowel disease: epidemiological evidence

RG Maunder, S Levenstein - Current molecular medicine, 2008 - ingentaconnect.com
Background: It is unclear whether psychological stress contributes to the inflammatory
process in the inflammatory bowel diseases (IBD), ulcerative colitis (UC) and Crohn's …

European evidence-based consensus on the management of ulcerative colitis: special situations

L Biancone, P Michetti, S Travis… - Journal of Crohn's …, 2008 - academic.oup.com
About 10–15% of patients with inflammatory bowel disease are diagnosed before the age of
18 years. 121 During puberty the incidence is 7 per 100 000 per year and increases further …